Ligand Pharmaceuticals Incorporated (LGND)
$301.81+2.31%Close
BUYRECOVERY · day 15
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6.0B
- Beta
- 1.01
- P/E (TTM)
- 29.66
- Short % float
- 13.70%
- Days to cover
- 8.7
- SI change
- +1.7%
- 1W
- -0.38%
- 1M
- +4.34%
- vs SPY 1W
- -1.54%
- vs SPY 1M
- +1.35%
Industry peers
FMP comparable companies · ranked by market cap
- CRNXBUYCrinetics Pharmaceuticals, Inc.$9.0BBULLQ 26$84.95+0.00%
- PRAXSELLPraxis Precision Medicines, Inc.$7.9BCRISISQ 11$283.56-1.40%
- BLTESELLBelite Bio, Inc$6.4BBEARQ 53$159.18+1.29%
- MIRMSELLMirum Pharmaceuticals, Inc.$5.0BRECOVERYQ 37$81.43+5.73%
- ACADSELLAcadia Pharmaceuticals Inc.$3.4BCRISISQ 18$20.11+1.02%
- VKTXSELLViking Therapeutics, Inc.$3.4BCRISISQ 22$29.28+2.81%
- DYNSELLDyne Therapeutics, Inc.$2.9BRECOVERYQ 3$15.44+1.65%
- SLNOSoleno Therapeutics, Inc.$2.8B$53.01
- NAMSSELLNewAmsterdam Pharma Company N.V.$2.7BCRISISQ 25$22.80+1.51%
- ADMABUYADMA Biologics, Inc.$2.3BRECOVERYQ 9$10.11+0.29%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on LGND?
- LOPJLB’s latest quantitative signal on Ligand Pharmaceuticals Incorporated (LGND) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is LGND in?
- Ligand Pharmaceuticals Incorporated (LGND) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Ligand Pharmaceuticals Incorporated (LGND) do?
- Ligand Pharmaceuticals Incorporated operates as a biopharmaceutical entity, primarily engaged in sourcing and advancing technologies to empower pharmaceutical companies globally in their efforts to discover and develop novel therapeutic solutions. Its diverse portfolio of commercialized products addresses a wide range of medical conditions. For hematologic malignancies, these include Kyprolis a…